Anti-C5 Antibody, C5 iRNA Dosing Regimens, Complement Diseases
Summary
Anti-C5 Antibody, C5 iRNA Dosing Regimens, Complement Diseases
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES
Application US20260097063A1 Kind: A1 Apr 09, 2026
Inventors
Umesh Chaudhari, Kuan-Ju Lin, Lorah Perlee, George D. Yancopoulos
Abstract
The present disclosure includes methods of treating C5-associated disease or disorder, such as myasthenia gravis, with a combination that includes an antibody or antigen-binding fragment thereof that binds specifically to C5 and a C5 iRNA which is a glycoconjugate that includes a ligand having terminal N-Acetylgalactosamine (GalNAc) residues and/or N-acetylglucosamine (GlcNAc) residues; or with the C5 iRNA monotherapy.
CPC Classifications
A61K 31/7125 A61K 31/122 A61K 31/198 A61K 31/4402 A61K 31/4709 A61K 31/475 A61K 31/519 A61K 31/616 A61K 31/727 A61K 33/06 A61K 38/13 A61K 39/3955 A61P 21/04 C07K 16/18 C12N 15/113 A61K 2039/54 A61K 2039/545 A61K 2039/55 C12N 2310/14 C12N 2310/315 C12N 2310/321 C12N 2310/322 C12N 2310/351
Filing Date
2025-10-01
Application No.
19347304
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.